company
Nova Vascular LLC dba NOVARX
Industry: pharmaceutical
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_warning_letter · labeling2026-06-08Nova Vascular LLC dba NOVARX — False & Misleading Claims/Misbranded (Telehealth) (2026-06-08)
Frequently asked questions
- How many FDA warning letters has Nova Vascular LLC dba NOVARX received?
- Argus HQ has recorded 1 FDA warning letter for Nova Vascular LLC dba NOVARX.
- What FDA recalls has Nova Vascular LLC dba NOVARX issued?
- Argus HQ has not recorded an FDA recall tied to Nova Vascular LLC dba NOVARX in our current dataset.
- Is Nova Vascular LLC dba NOVARX FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 1 warning letter, 0 recalls, and 0 approval records for Nova Vascular LLC dba NOVARX. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

